Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis

    Isoniazid is a first-line antituberculosis agent with high variability, which would profit from individualized dosing. Concentrations of isoniazid at 2 h (C2h), as an indicator of safety and efficacy, are importa...

    Bo-Hao Tang, **n-Fang Zhang, Shu-Meng Fu, Bu-Fan Yao in Clinical Pharmacokinetics (2024)

  2. No Access

    Article

    Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions

    The activity changes of cytochrome P450 (CYP450) enzymes, along with the complicated medication scenarios in diabetes mellitus (DM) patients, result in the unanticipated pharmacokinetics (PK), pharmacodynamics...

    Yafen Li, **aonan Li, Miao Zhu, Huan Liu, Zihan Lei in Clinical Pharmacokinetics (2024)

  3. No Access

    Article

    Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis

    Allergen-specific immunotherapy (AIT) plays a pivotal role in altering the immune status and tissue responses in allergic rhinitis (AR). This study focuses on the impact of sublingual immunotherapy (SLIT) invo...

    Yue Pan, **nxin Zhang, Huanting Geng, Yan Yu, Jianyong Liu in Advances in Therapy (2024)

  4. No Access

    Article

    Artificial Intelligence in Liver Diseases: Recent Advances

    Liver diseases cause a significant burden on public health worldwide. In spite of great advances during recent years, there are still many challenges in the diagnosis and treatment of liver diseases. During re...

    Feifei Lu, Yao Meng, **aoting Song, **aotong Li, Zhuang Liu in Advances in Therapy (2024)

  5. Article

    Open Access

    Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI)

    Anemia of chronic kidney disease (CKD) has a high incidence and is associated with many disease conditions. Iron dysmetabolism is an important contributor to anemia in CKD patients.

    Haiting Wu, Hong Cheng, Caili Wang, Li Yao, Shuguang Qin, Li Zuo in Advances in Therapy (2024)

  6. Article

    Open Access

    Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension

    In the event-driven FREEDOM-EV trial, oral treprostinil delayed clinical worsening in patients with pulmonary arterial hypertension (PAH). Open-label extension studies offer additional data about tolerability,...

    Ekkehard Grünig, Franck Rahaghi, Jean Elwing, Carmine Dario Vizza in Advances in Therapy (2024)

  7. No Access

    Article

    Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”

    Thomas Yen-Ting Chen, Qianru Zhang, Yao-Min Hung, Renin Chang, Shiow-Ing Wang in Drugs (2024)

  8. No Access

    Article

    Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China

    PB201 is an orally active, partial glucokinase activator targeting both pancreatic and hepatic glucokinase. As the second glucokinase activator studied beyond phase I, PB201 has demonstrated promising glycemic...

    Ling Song, Fangrui Cao, Shu Niu, Michael Xu, Ruifang Liang in Clinical Pharmacokinetics (2024)

  9. No Access

    Article

    Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study

    Venous thromboembolism (VTE) consists of deep vein thrombosis (DVT) and pulmonary embolism (PE). Rivaroxaban is a direct oral anticoagulant (DOAC) inhibiting activated coagulation factor X (FXa), and exerts se...

    Kepeng Lu, Qian-Qian Liao, Ke-Wei Zhu, Ying Yao, **ao-Jiao Cui in Advances in Therapy (2024)

  10. Article

    Open Access

    Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways

    The FLT3/ITD mutation exists in many acute myeloid leukemia (AML) patients and is related to the poor prognosis of patients. In this study, we attempted to evaluate the antitumor activity of simvastatin, a member...

    Genhong Li, **gwei Yao, Zhen Lu, Lian Yu, Qinwei Chen, Lihong Ding in Drugs in R&D (2023)

  11. No Access

    Article

    Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein Level and Osteoporosis

    The mechanistic target of rapamycin (mTOR) regulates bone homeostasis, a crucial factor in osteoporosis (OP) development. However, most research is based on observational studies, and the causality remains unc...

    Ting Cheng, Yao-Chen Zhang, Ke-Yi Fan, **g-** Hu, Qian Wang in Advances in Therapy (2023)

  12. Article

    Correction to: Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts—A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol

    Yunpeng Zhu, Kaijie Qin, Yun Liu, Haoyi Yao, Wei Zhang, Qiang Zhao in Advances in Therapy (2023)

  13. Article

    Open Access

    An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer

    Epithelial–mesenchymal transition (EMT) is an important biological process in tumor invasion and metastasis, and thus a potential indicator of the progression and drug resistance of breast cancer. This study c...

    Bo Zhang, Rong Zhao, Qi Wang, Ya-**g Zhang, Liu Yang, Zhou-Jun Yuan in Advances in Therapy (2023)

  14. No Access

    Article

    Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis

    Lymph node metastasis is a cause of poor prognosis in breast cancer. Mass spectrometry-based proteomics aims to map the protein landscapes of biological samples and profile tumors more comprehensively. Here, p...

    Yu-Lu Sun, Yi-**n Zhao, Yi-Nan Guan, **n You, Yin Zhang, Meng Zhang in Advances in Therapy (2023)

  15. Article

    Correction to: Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study

    Thomas Yen-Ting Chen, Shiow-Ing Wang, Yao-Min Hung, Joshua J. Hartman, Renin Chang in Drugs (2023)

  16. No Access

    Article

    Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts—A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol

    The current evidence for chronic oral antispastic medication use after coronary artery bypass grafting using radial artery grafts (RA-CABG) is controversial. Calcium channel blockers, such as diltiazem, are th...

    Yunpeng Zhu, Kaijie Qin, Yun Liu, Haoyi Yao, Wei Zhang, Qiang Zhao in Advances in Therapy (2023)

  17. No Access

    Article

    Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates

    High variability in vancomycin exposure in neonates requires advanced individualized dosing regimens. Achieving steady-state trough concentration (C0) and steady-state area-under-curve (AUC0–24) targets is import...

    Bo-Hao Tang, **-Yuan Zhang, Karel Allegaert, Guo-**ang Hao in Clinical Pharmacokinetics (2023)

  18. Article

    Open Access

    Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study

    Abiraterone acetate tablet is an inhibitor of androgen synthesis, primarily for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This study evaluated the bioequivalence and pharmacokin...

    Zhao-xin Wu, Chen-**g Wang, ** Shi, Yan-** Liu, Ting Li, Fei-fei Sun in Drugs in R&D (2023)

  19. No Access

    Article

    Study Protocol of a Multicenter, Randomized, Single-Blind Trial: Efficacy and Safety of Remimazolam Tosylate for Sedation in ICU Patients

    Pharmacodynamic and pharmacokinetic studies in animal experiments and a phase 1 study suggested remimazolam tosylate as an effective and safe sedation/anesthetic agent. However, the effects and safety dose of ...

    Ning Liu, Zhiyi Jiang, Yao Nie, Lingyun Zuo, Chuanxi Chen, **ang Si in Advances in Therapy (2023)

  20. No Access

    Article

    The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials

    Pharmacological treatment is common in practice and widely used for the management of insomnia. However, evidence comparing the relative effectiveness, safety, and certainty of evidence among drug classes and ...

    Bei Pan, Long Ge, Honghao Lai, Liangying Hou, Chen Tian, Qi Wang, Kelu Yang in Drugs (2023)

previous disabled Page of 3